PROJECT PURPOSE

OSU is developing a state-of-the-art Institute for Human Performance and Nutrition to provide wrap-around elite human performance research that will bring together multi-disciplinary University research programs in order to create predictive and therapeutic innovations in training, recovery, injury reduction and mental readiness. OSU?s unique advantage of a presence in all 77 counties will serve as a resource for practitioners and families, and the Institute will help not only better understand particular issues like the long-term impact of COVID on individuals engaged in athletics, but will also help the State as it addresses obesity, diabetes, and cardiovascular disease, which disproportionately impact the State?s underserved and vulnerable population. The Institute will leverage OSU?s highly successful ECHO program, creating ECHO lines focused on extending athletic training to coaches, athletic directors and nurses in current knowledge on nutrition, human performance, and injury to improve the health and well-being of students and athletes in Oklahoma. In addition, ECHO lines will be expanded to focus research applications on obesity and diabetes education for primary care providers across the state. Research and programs conducted at The Institute will further OSU?s continued focus and mission to provide better health outcomes for the entire state.

EVIDENCE

A vast body of external research supports the evidence-based approach proposed in this project, including the consensus work from Federal institutes, leading medical journals and prominent academic centers. Representative validation includes: ? Carfì A., et al. ?Persistent Symptoms in Patients After Acute COVID-19.? JAMA. ? Lu Y., et al. ?Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke.? Lancet. ? Baillargeon A, et al. ?Neuropsychological and neurophysiological assessment of sport concussion in children, adolescents and adults.? Brain Injury. ? Zanuso S, et al. ?Exercise for the management of type 2 diabetes: a review of the evidence.? Acta Diabetol.


POPULATION DESCRIPTION

In addition to direct applications for elite athletes throughout the country, research conducted at the Institute will be applied to develop translational applications aimed at improving health outcomes across Oklahoma's tribal, Indigenous and other marginalized populations. Such groups routinely experience acutely adverse health outcomes and suffered higher levels of impact from Covid-19 owing to the prevalence of co-morbidities within their populations. The Institute's research will target obesity, diabetes and heart disease, bringing to bear findings and therapeutic approaches applicable not only to the majority of Oklahoma citizens, but particularly to the least economically-advantaged and most vulnerable.

PERFORMANCE MEASURING

As an R1 university with a comprehensive research program across disciplines, Oklahoma State University has robust mechanisms and standard research protocols in place for capturing information, measuring project performance and utilizing data from test subjects. Leveraging the strength of OSU Medicine and the University?s standard research processes, human subject information will be handled in strict accordance with well-defined and generally accepted medical and scholarly practices.


ONGOING INVESTMENT AMOUNT

$

ONGOING INVESTMENT DESCRIPTION

None

ONGOING INVESTMENT REQUIRED

Able to continue operation without additional funding from the State of Oklahoma


PROGRAM CATEGORY

Public Health Expenditures


PROGRAM SUBCATEGORY

Capital Investments or Physical Plant Changes to Public Facilities that respond to the COVID-19 public health emergency


FEDERAL GRANT AMOUNT

$

FEDERAL GRANT DESCRIPTION

Federal research grants


HQ COUNTY

Payne


ENTITY TYPE

Other non or not-for profit entity


Data source: Oklahoma Office of Management and Enterprise Services / More information »